Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target.
Saved in:
| Title: | Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target. |
|---|---|
| Authors: | Kroenke MA; Clinical Immunology, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Barger TE; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States., Hu J; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States., Miller MJ; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States., Kalenian K; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States., He L; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States., Hsu H; Inflammation Research, Amgen, Thousand Oaks, CA, United States., Bartley Y; Global Safety, Amgen, Thousand Oaks, CA, United States., Chow VF; Clinical Pharmacology, Modeling and Simulation, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Teixeira Dos Santos MC; Clinical Biomarkers and Diagnostics, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Sullivan BA; Clinical Biomarkers and Diagnostics, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Cheng LE; Early Development, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Parnes JR; Early Development, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Padaki R; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States., Kuhns S; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States., Mytych DT; Clinical Immunology, Translational Medicine, Amgen, Thousand Oaks, CA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Dec 14; Vol. 12, pp. 782788. Date of Electronic Publication: 2021 Dec 14 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34970265 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kroenke+MA%22">Kroenke MA</searchLink>; Clinical Immunology, Translational Medicine, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Barger+TE%22">Barger TE</searchLink>; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Hu+J%22">Hu J</searchLink>; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Miller+MJ%22">Miller MJ</searchLink>; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Kalenian+K%22">Kalenian K</searchLink>; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22He+L%22">He L</searchLink>; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Hsu+H%22">Hsu H</searchLink>; Inflammation Research, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Bartley+Y%22">Bartley Y</searchLink>; Global Safety, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Chow+VF%22">Chow VF</searchLink>; Clinical Pharmacology, Modeling and Simulation, Translational Medicine, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Teixeira+Dos+Santos+MC%22">Teixeira Dos Santos MC</searchLink>; Clinical Biomarkers and Diagnostics, Translational Medicine, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Sullivan+BA%22">Sullivan BA</searchLink>; Clinical Biomarkers and Diagnostics, Translational Medicine, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Cheng+LE%22">Cheng LE</searchLink>; Early Development, Translational Medicine, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Parnes+JR%22">Parnes JR</searchLink>; Early Development, Translational Medicine, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Padaki+R%22">Padaki R</searchLink>; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Kuhns+S%22">Kuhns S</searchLink>; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Mytych+DT%22">Mytych DT</searchLink>; Clinical Immunology, Translational Medicine, Amgen, Thousand Oaks, CA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2021 Dec 14; Vol. 12, pp. 782788. <i>Date of Electronic Publication: </i>2021 Dec 14 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34970265 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2021.782788 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 782788 Titles: – TitleFull: Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kroenke MA – PersonEntity: Name: NameFull: Barger TE – PersonEntity: Name: NameFull: Hu J – PersonEntity: Name: NameFull: Miller MJ – PersonEntity: Name: NameFull: Kalenian K – PersonEntity: Name: NameFull: He L – PersonEntity: Name: NameFull: Hsu H – PersonEntity: Name: NameFull: Bartley Y – PersonEntity: Name: NameFull: Chow VF – PersonEntity: Name: NameFull: Teixeira Dos Santos MC – PersonEntity: Name: NameFull: Sullivan BA – PersonEntity: Name: NameFull: Cheng LE – PersonEntity: Name: NameFull: Parnes JR – PersonEntity: Name: NameFull: Padaki R – PersonEntity: Name: NameFull: Kuhns S – PersonEntity: Name: NameFull: Mytych DT IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 12 Text: 2021 Dec 14 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |